Extent of correlation between first and second trimester markers for Down's syndrome screening

Journal of Medical Screening

Volumn 7, Issue 3, 2000, Pages 163-

  De Biasio, Pierangela ^a   Canini, Silvana ^b   Prefumo, Federico ^a   Famularo, Luciano ^b   Venturini, Pier Luigi ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION FUNCTION; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ESTRADIOL; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 0033665886     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.7.3.163     Document Type: Article

References (5)

1. Maternal serum screening for Down's syndrome in early pregnancy
2. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation
3. First-trimester screening for Down syndrome using nuchal translucency measurement with free -hCG and PAPP-A between 10 and 13 weeks of pregnancy: The combined test
4. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters
5. First trimester nuchal translucency and second trimester serum screening for fetal Down's syndrome [abstract]